BUZZ-Nvidia-backed Recursion Pharmaceuticals falls on bigger-than-expected Q4 loss
ReutersFeb 28, 2025 2:41 PM
Shares of Nvidia-backed AI drug developer Recursion Pharmaceuticals RXRX.O fall 13% to $6.67 premarket
The company posts Q4 revenue of $4.5 million, missing analysts' estimate of $19 million, according to data compiled by LSEG
Reports Q4 net loss of 53 cents per share versus a loss estimate of 43 cents per share
Recursion wants to be the Amazon Prime of pharma by adopting a subscription model for selling its pipeline of medicines, Bloomberg reports
The company files for stock offering of up to $500 million - filing
It has ~390 mln outstanding shares, with a market capitalization of $3 bln, according to data compiled by LSEG
RXRX has fallen ~51% in the last 12 months
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).TradingKey
9 hours ago
Why Sanae Takaichi Winning Japan’s Diet Election Led to a Surge in Japanese Stock Indices？
TradingKey - Reports indicate that the ruling coalition led by Japanese Prime Minister Sanae Takaichi has secured a single-party majority in the parliamentary elections held on Sunday (February 8). Following the news, the yen weakened slightly, while the Nikkei Index surpassed 57,000 for the first tTradingKey
10 hours ago
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.TradingKey
Fri, Feb 6
Is Bitcoin’s Four-Year Cycle Dead in 2026?
Is the Bitcoin 4-year cycle dead? After 2025 broke historical records with a red post-halving year, institutional analysts explore if the Bitcoin price has decoupled from the halving countdown. Analyze the impact of spot ETFs, global liquidity, and the roadmap to the 2028 halving in this 2026 marketTradingKey
Wed, Feb 4
